KRQE Blogs

Renibus Therapeutics Announces Completion of Enrollment in PROTECT, a Pivotal Phase 3 Clinical Trial of RBT-1 to Reduce the Risk of Post-Operative Complications After Cardiac ...

SOUTHLAKE, Texas, April 24, 2025 /PRNewswire/ -- Renibus Therapeutics ® ("Renibus"), a clinical late-stage biopharmaceutical company focusing on the prevention and treatment of cardiac, renal, and ...
Business Wire

Cascade Chemistry Selected to Produce Active Pharmaceutical Ingredient for Clinical Trial Supplies of COVID-19 Investigational Drug RBT-9

EUGENE, Ore.--(BUSINESS WIRE)--Cascade Chemistry, a leading contract research and manufacturing organization serving the pharmaceutical, materials, and chemical industries, today announced that it has ...
Business Wire

Frontier Scientific Develops and Provides Process to Produce Active Pharmaceutical Ingredient for Clinical Trial of COVID-19 Therapeutic Investigational Drug RBT-9

LOGAN, Utah--(BUSINESS WIRE)--Frontier Scientific, a world leader in porphyrin chemistry and chemical building blocks for drug discovery and material science research, today announced their ...
FierceBiotech

Renibus’ cardiac surgery drug aces phase 2 trial as biotech adds extra CEO

Renibus Therapeutics’ lead candidate for patients undergoing cardiac surgery has sailed through a phase 2 trial, setting up the Texan biotech for a late-stage study in the coming months as it also ...